|
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801 |
|
|
|
Titel: |
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801 |
Auteur: |
Hosokawa, Shinobu Ichihara, Eiki Harada, Daijiro Kuyama, Shoichi Inoue, Koji Gemba, Kenichi Ichikawa, Hirohisa Kato, Yuka Oda, Naohiro Oze, Isao Tamura, Tomoki Kozuki, Toshiyuki Umeno, Takahiro Kubo, Toshio Hotta, Katsuyuki Bessho, Akihiro Maeda, Yoshinobu Kiura, Katsuyuki |
Verschenen in: |
International journal of clinical oncology |
Paginering: |
Jaargang 27 () nr. 7 pagina's 1139-1144 |
Jaar: |
2022-05-10 |
Inhoud: |
|
Uitgever: |
Springer Nature Singapore, Singapore |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|